Mead Johnson Nutrition Company

Bristol-myers Squibb Compnay

Mjn U.S. Holdings LLC

Udo Herz

Harald Renz

Holger Garn

Nicole Bluemer

Robert J McMahon

Josef Neu

William Michael Russell

Margarete Focke-Tejkl

Ines Swoboda

Heidrun Hochwallner

Ulrike Schulmeister

Margarte Focke-Tejkl

Ric Van Tol

Rudolph Valenta

Robert J Mcmahon

Eric AF Van Tol

Karin M Overkamp

Machtelt Braaksma

The present disclosure is directed to a novel nutritional formula for treating or preventing systemic inflammation in a subject. The nutritional formula comprises a therapeutically effective amount of inactivatedGG (LGG).

Method for reducing or preventing systemic inflammation

A children's or infant's nutritional product utilizing or containing one or more inactivated probiotics for preventing or reducing systemic and/or respiratory inflammation in a child or infant.

Method for the utilization of and product containing inactivated probiotic

A method for identifying allergenic proteins and peptides. More specifically, a method for identifying allergenic milk proteins and/or peptides including the steps of: providing at least one expression library comprising DNA or cDNA derived from the mammary gland tissue of a lactating cow, expressing at least one protein or peptide encoded by said expression library, determining the binding capacity of said at least one protein or peptide to IgE of at least one serum of an individual who is sensitive to cow's milk, contacting the at least one protein or peptide exhibiting an IgE binding capacity as determined in step c) with basophil cells, eosinophil cells or mast cells and identifying the at least one protein or peptide as being allergenic when said basophil cells, eosinophil cells or mast cells release upon contact with at least one protein or peptide of step d) at least one mediator.

Method for identifying allergenic proteins and peptides

The present invention is directed to a novel method for preventing or treating the development of respiratory allergies. The method comprises prenatal and/or postnatal administration of a therapeutically effective amount of LGG.

Method for preventing or treating the development of respiratory allergies

Growing community of inventors

Kirchhain, Germany

Udo Herz